Jeffrey Freiberg, MD, PhD

home / authors / jeff-freiberg-md-phd

Assistant Professor of Medicine Division of Infectious Diseases at Vanderbilt University Medical Center.

Articles

2024 S aureus and MRSA Trials: Key Takeaways

February 25th 2025

Jeffrey Freiberg, MD, PhD review of the SABATO trial on oral antibiotics for S aureus bacteremia and a comparison of mupirocin and iodine treatments for MRSA decolonization.

Antibiotic Resistance in the Context of UTI Treatment Developments

Sophia Abene;Jeffrey Freiberg, MD, PhD

February 24th 2025

Jeffery Freiberg, MD, PhD review on key trials and challenges from 2024 in the fight against antibiotic resistance in complicated and uncomplictaed UTIs, including cefepime-taniborbactam and gepotidacin.

Emerging Threats and Key Knowledge From 2024 Trending Into 2025

Sophia Abene;Jeffrey Freiberg, MD, PhD

February 21st 2025

Jeff Freiberg, MD, PhD, on the rising emerging infection concerns of dengue, mpox, measles, and H5N1 influenza in clinical practice.